Healthcare provider profile · identity verified

Nathan Herling Moore, MD

Internal Medicine · SAINT LOUIS, MO · NPI 1093154254

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	864	235
Amlodipine Besylate	Amlodipine Besylate	512	141
Losartan Potassium	Losartan Potassium	414	121
Rosuvastatin Calcium	Rosuvastatin Calcium	357	81
Omeprazole	Omeprazole	321	97
Levothyroxine Sodium	Levothyroxine Sodium	317	68
Lisinopril	Lisinopril	261	78
Metformin Hcl	Metformin Hcl	231	59
Hydrochlorothiazide	Hydrochlorothiazide	227	61
Metoprolol Succinate	Metoprolol Succinate	222	56
Tamsulosin Hcl	Tamsulosin Hcl	216	61
Metoprolol Tartrate	Metoprolol Tartrate	195	44
Furosemide	Furosemide	161	50
Ezetimibe	Ezetimibe	160	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	159	37
Gabapentin	Gabapentin	156	52
Carvedilol	Carvedilol	147	42
Eliquis	Apixaban	147	34
Allopurinol	Allopurinol	145	40
Pantoprazole Sodium	Pantoprazole Sodium	145	41
Alprazolam	Alprazolam	136	30
Trazodone Hcl	Trazodone Hcl	120	30
Montelukast Sodium	Montelukast Sodium	114	27
Arexvy	Rsvpref3 Antigen/As01e/Pf	112	112
Potassium Chloride	Potassium Chloride	108	33
Simvastatin	Simvastatin	108	31
Spironolactone	Spironolactone	104	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	96	20
Lovastatin	Lovastatin	94	24
Metformin Hcl Er	Metformin Hcl	94	30
Sertraline Hcl	Sertraline Hcl	94	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	26
Escitalopram Oxalate	Escitalopram Oxalate	89	22
Jardiance	Empagliflozin	88	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	86	24
Finasteride	Finasteride	84	27
Fluticasone Propionate	Fluticasone Propionate	81	27
Pravastatin Sodium	Pravastatin Sodium	81	21
Hydroxyzine Hcl	Hydroxyzine Hcl	79	28
Glipizide	Glipizide	75	22
Clopidogrel	Clopidogrel Bisulfate	73	27
Zolpidem Tartrate	Zolpidem Tartrate	73	19
Tramadol Hcl	Tramadol Hcl	71	29
Fluoxetine Hcl	Fluoxetine Hcl	70	suppressed
Alendronate Sodium	Alendronate Sodium	67	19
Duloxetine Hcl	Duloxetine Hcl	67	16
Mirtazapine	Mirtazapine	66	18
Meloxicam	Meloxicam	65	16
Atenolol	Atenolol	64	18
Ramipril	Ramipril	62	18
Bupropion Xl	Bupropion Hcl	60	16
Tizanidine Hcl	Tizanidine Hcl	60	14
Buspirone Hcl	Buspirone Hcl	59	19
Pregabalin	Pregabalin	59	14
Trulicity	Dulaglutide	58	suppressed
Colesevelam Hcl	Colesevelam Hcl	57	suppressed
Memantine Hcl	Memantine Hcl	53	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	suppressed
Diazepam	Diazepam	52	15
Enalapril Maleate	Enalapril Maleate	52	13
Oxycodone Hcl	Oxycodone Hcl	52	suppressed
Farxiga	Dapagliflozin Propanediol	50	11
Clonazepam	Clonazepam	48	12
Hydralazine Hcl	Hydralazine Hcl	47	suppressed
Myrbetriq	Mirabegron	47	suppressed
Citalopram Hbr	Citalopram Hydrobromide	46	11
Nifedipine Er	Nifedipine	46	suppressed
Rybelsus	Semaglutide	46	12
Lorazepam	Lorazepam	45	19
Albuterol Sulfate Hfa	Albuterol Sulfate	44	26
Ozempic	Semaglutide	43	11
Prednisone	Prednisone	42	19
Donepezil Hcl	Donepezil Hcl	40	12
Ondansetron Odt	Ondansetron	37	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Baclofen	Baclofen	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	suppressed
Ipratropium Bromide	Ipratropium Bromide	32	12
Warfarin Sodium	Warfarin Sodium	32	suppressed
Sodium Chloride	0.9 % Sodium Chloride	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Famotidine	Famotidine	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Lactulose	Lactulose	27	suppressed
Azithromycin	Azithromycin	26	20
Tadalafil	Tadalafil	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Repatha Sureclick	Evolocumab	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Temazepam	Temazepam	23	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Valsartan	Valsartan	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Linzess	Linaclotide	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Cephalexin	Cephalexin	13	13
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error